JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Cash Flow for Dividends: ฿-25.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:JSP JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP
80 GF Score
Price ฿1.78
GF Value ฿3.16
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Cash Flow for Dividends?

JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP 80 Cash Flow for Dividends is ฿-25.0 Mil as of Mar. 2026. GuruFocus rates BKK:JSP with a GF Score™ of 80/100 and a GF Value™ of ฿3.16 (Significantly Undervalued). The stock has 5 warning signs investors should review.

JSP Pharmaceutical Manufacturing (Thailand) PCL's cash flow for dividends for the three months ended in Mar. 2026 was ฿0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ฿-25.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

JSP Pharmaceutical Manufacturing (Thailand) PCL's quarterly payment of dividends declined from Sep. 2025 (฿-24.9 Mil) to Dec. 2025 (฿-0.0 Mil) and declined from Dec. 2025 (฿-0.0 Mil) to Mar. 2026 (฿0.0 Mil).

JSP Pharmaceutical Manufacturing (Thailand) PCL's annual payment of dividends increased from Dec. 2023 (฿-11.0 Mil) to Dec. 2024 (฿-15.0 Mil) and increased from Dec. 2024 (฿-15.0 Mil) to Dec. 2025 (฿-25.0 Mil).

JSP Pharmaceutical Manufacturing (Thailand) PCL Cash Flow for Dividends Related Terms

JSP Pharmaceutical Manufacturing (Thailand) PCL Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JSP Pharmaceutical Manufacturing (Thailand) PCL Cash Flow for Dividends Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial -28.00 -6.00 -11.00 -14.99 -24.95

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 -24.94 -0.01 0.00
BKK:JSP
80GF Score
JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JSP Pharmaceutical Manufacturing (Thailand) PCL Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-25.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ฿-25.0 Mil mean?
JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) has a Cash Flow for Dividends of ฿-25.0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL's Cash Flow for Dividends too high?
JSP Pharmaceutical Manufacturing (Thailand) PCL's current Cash Flow for Dividends is ฿-25.0 Mil. Overall, JSP Pharmaceutical Manufacturing (Thailand) PCL has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JSP Pharmaceutical Manufacturing (Thailand) PCL's Cash Flow for Dividends compare to KHC and GIS?
JSP Pharmaceutical Manufacturing (Thailand) PCL's Cash Flow for Dividends of ฿-25.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Consumer Packaged Goods company?
A good Cash Flow for Dividends depends on the Consumer Packaged Goods industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. JSP Pharmaceutical Manufacturing (Thailand) PCL's current Cash Flow for Dividends is ฿-25.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL stock overvalued right now?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿3.16, compared to a current price of ฿1.78 — trading 43.7% below its estimated fair value. The current Cash Flow for Dividends is ฿-25.0 Mil. JSP Pharmaceutical Manufacturing (Thailand) PCL's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP), the current Cash Flow for Dividends is ฿-25.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Overvalued in 2026?

Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL stock appears to be undervalued. The current stock price of ฿1.78 is trading 43.7% below its estimated GF Value™ of ฿3.16. GuruFocus considers JSP Pharmaceutical Manufacturing (Thailand) PCL to be Significantly Undervalued.

Key valuation signals for BKK:JSP:

  • Cash Flow for Dividends: ฿-25.0 Mil
  • GF Value™: ฿3.16 vs. price of ฿1.78 (43.7% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the BKK:JSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JSP Pharmaceutical Manufacturing (Thailand) PCL Business Description

Address No. 255, 257 Soi Sathupradit 58, Bang Pongphang, Yan Nawa, Bangkok, THA, 10120
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing modern medicine, traditional medicine, herbal products, dietary supplements, medical supplies, and cleaning alcohol under the client's and the company's own trademarks. Maximum revenue for the company is generated from the sale of dietary supplements. The Group's reportable operating segments are: Manufacture and distribution of products under the company's brand name (Own brands), which generate maximum revenue, Manufacture and distribution of products under customers' brand name (OEM), Manufacture and distribution of hemodialysis solution and related medical supplies; and Service, research and development, and healthcare products training. Geographically, it operates principally in Thailand.
80GF Score

Get the complete analysis for BKK:JSP

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.78
Price
฿3.16
GF Value